Eli Lilly (NYSE: LLY) and Johnson & Johnson (NYSE: JNJ) both delivered strong third-quarter results, but their earnings ...

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.

Novo Nordisk (NVO) downgraded to Hold after FDA GLP-1 actions and 2026 patent cliffs threaten Wegovy supply and growth. See ...

On Friday, Novo Nordisk (NVO) shares saw an increase in pre-market trading. This market movement is directly linked to a new initiative by Amazon’s digital pharmacy. The platform announced it ...

President Donald Trump isn’t opposed to using weight-loss drugs. Trump, 79, addressed concerns about his health during a ...

Health-care companies rose amid deal intrigue. Merck has entered talks to acquire Revolution Medicines in a deal that could value it at around $30 billion. Biopharmaceutical company AbbVie had ...

With prices starting at $149 for cash-paying patients, the new Wegovy pill undercuts much of the current market.

The pill version of popular weight-loss drug Wegovy became available in the U.S. on Monday, offering patients a daily oral ...

With Johnson & Johnson’s participation, 15 of 17 companies contacted by the administration over the summer have now signed on ...

The new oral Wegovy, launched this week, contains semaglutide, the same active ingredient as injectable Wegovy and Ozempic ...

Parabilis Medicines raised $305 million in a Series F round led by RA Capital, Fidelity and Janus Henderson, with crossover ...